fda approved semaglutide for weight loss approves higher dose of Wegovy to increase patient Kids approved for weight loss

Current guidelines tend to prioritize starting a GLP-1 medication for people who already have cardiovascular or kidney disease, or for those where weight management is a concern

Gradual dose reduction may be considered in some circumstances, though this is not universally necessary

And thats where I think theres going to be some confusion, says Leigh Purvis, prescription drug policy principal at AARPs Public Policy Institute

Within the SELECT population with BMI 30 kg m 2 or 27 kg m 2 with at least one obesity-related comorbidity, the mean weight loss was 14.9% at week 68, compared with 2.4% with placebo 14

In the UK, these are primarily regulated as food supplements rather than licensed medicines